Betty Tai

National Institutes of Health — United States

Medicine · Health Sciences

21h-index1.5kcitations49works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(20), Opioid Use Disorder Treatment(17), Health Policy Implementation Science(7), Pharmaceutical Practices and Patient Outcomes(6), Schizophrenia research and treatment(5)

Publications49 total

Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
Addiction Science & Clinical Practice·2024· 5 citedOpen Access
Sex differences in weight gain during medication-based treatment for opioid use disorder: A meta-analysis and retrospective analysis of clinical trial data
Drug and Alcohol Dependence·2022· 10 citedOpen Access
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic
Addiction Science & Clinical Practice·2021· 8 citedOpen Access
Prevalence of obesity among U.S. population with substance dependence
Drug and Alcohol Dependence·2020· 2 cited
Response to commentaries
Addiction·2019
Measurement‐based care using DSM‐5 for opioid use disorder: can we make opioid medication treatment more effective?
Addiction·2019· 79 citedOpen Access
A Quality Framework for Emergency Department Treatment of Opioid Use Disorder
Annals of Emergency Medicine·2018· 60 cited
Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials
Drug and Alcohol Dependence·2018· 13 cited
High Expression of FGF2/SDC1 Signaling Contributes to Poor Clinical Outcome in Hodgkin Lymphoma Patients and SDC1 siRNA Suppresses Proliferation, Migration, and Invasion in Hodgkin Lymphoma Cells
Blood·2017
The 2017 CALDAR Summer Institute and International Conference Promoting Global Health—Precision Research in Substance Abuse, HIV, and Care
Journal of Neuroimmune Pharmacology·2017· 2 cited
Using electronic health records data for clinical research
Drug and Alcohol Dependence·2017
Pediatric Hodgkin lymphoma- biomarkers, drugs, and clinical trials for translational science and medicine
Oncotarget·2016· 46 citedOpen Access
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
Oncotarget·2016· 202 citedOpen Access
Alternative endpoints based on health outcomes in stimulant users trials
Drug and Alcohol Dependence·2015
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
Oncotarget·2015· 94 citedOpen Access
NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research
Frontiers in Psychiatry·2015· 11 citedOpen Access
Patient registries for substance use disorders
Substance Abuse and Rehabilitation·2014· 8 citedOpen Access
Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings
Substance Abuse and Rehabilitation·2014· 9 citedOpen Access
Body mass index (BMI) and obesity prevalence among substance abuse participants from NIDA's clinical trials network
Drug and Alcohol Dependence·2014
Challenges and Opportunities for Integrating Preventive Substance-Use-Care Services in Primary Care through the Affordable Care Act
Journal of Health Care for the Poor and Underserved·2014· 56 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Udi E. Ghitza(13), Lian Hu(7), Li‐Tzy Wu(6), Robert Lindblad(5), Nora D. Volkow(5), Paul VanVeldhuisen(5), Mohamed R. Akl(4), Poonam Nagpal(4), André Goy(4), K. Stephen Suh(4), David Liu(4), Steven Sparenborg(4), Robert E. Gore‐Langton(4), Nehad M. Ayoub(3), Sathyen A. Prabhu(3), Matthew Gliksman(3), A. John Rush(3), Michele Straus(3), Andrew J. Saxon(3), Dan G. Blazer(3)